These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10212010)

  • 1. The outcome of very low dosages of simvastatin in patients with hypercholesterolemia.
    Rindone JP
    Pharmacotherapy; 1999 Apr; 19(4):399-403. PubMed ID: 10212010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.
    Ose L; Davidson MH; Stein EA; Kastelein JJ; Scott RS; Hunninghake DB; Campodonico S; Insull W; Escobar ID; Schrott HG; Stepanavage ME; Wu M; Tate AC; Melino MR; Mercuri M; Mitchel YB
    Clin Cardiol; 2000 Jan; 23(1):39-46. PubMed ID: 10680028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group.
    Stein EA; Davidson MH; Dobs AS; Schrott H; Dujovne CA; Bays H; Weiss SR; Melino MR; Stepanavage ME; Mitchel YB
    Am J Cardiol; 1998 Aug; 82(3):311-6. PubMed ID: 9708659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy modifications and low-density lipoprotein cholesterol goal attainment rates associated with the initiation of generic simvastatin.
    Willey VJ; Bullano MF; Shoetan NN; Gandhi SK
    Curr Med Res Opin; 2010 Jan; 26(1):121-8. PubMed ID: 19916706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S; Bentivoglio M; Conti R; Osanna RA; Savino K; Zollino L; Corea L
    Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients.
    Averna M; Zaninelli A; Le Grazie C; Gensini GF
    J Clin Lipidol; 2010; 4(4):272-8. PubMed ID: 21122660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale, design, and baseline results of the Pravastatin-to-Simvastatin Conversion Lipid Optimization Program (PSCOP).
    Ito MK; Stolley SN; Morreale AP; Lin JC; Marcus DB
    Am J Health Syst Pharm; 1999 Jun; 56(11):1107-13. PubMed ID: 10385458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk.
    Rosen JB; Ballantyne CM; Hsueh WA; Lin J; Shah AK; Lowe RS; Tershakovec AM
    Lipids Health Dis; 2015 Sep; 14():103. PubMed ID: 26336957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid effects of simvastatin on lipid profile and C-reactive protein in patients with hypercholesterolemia.
    Li JJ; Chen MZ; Chen X; Fang CH
    Clin Cardiol; 2003 Oct; 26(10):472-6. PubMed ID: 14579918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia.
    Farnier M; Guyton JR; Jensen E; Polis AB; Johnson-Levonas AO; Brudi P
    Atherosclerosis; 2013 Aug; 229(2):415-22. PubMed ID: 23880197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER.
    Karlson BW; Wiklund O; Palmer MK; Nicholls SJ; Lundman P; Barter PJ
    Eur Heart J Cardiovasc Pharmacother; 2016 Oct; 2(4):212-7. PubMed ID: 27533947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study).
    Robinson JG; Ballantyne CM; Grundy SM; Hsueh WA; Parving HH; Rosen JB; Adewale AJ; Polis AB; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2009 Jun; 103(12):1694-702. PubMed ID: 19539078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use and effect of simvastin in patients with type II diabetes].
    Camarda G
    Clin Ter; 1993 Aug; 143(2):105-7. PubMed ID: 8222540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study).
    Garmendia F; Brown AS; Reiber I; Adams PC
    Curr Med Res Opin; 2000; 16(3):208-19. PubMed ID: 11191012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
    Knapp HH; Schrott H; Ma P; Knopp R; Chin B; Gaziano JM; Donovan JM; Burke SK; Davidson MH
    Am J Med; 2001 Apr; 110(5):352-60. PubMed ID: 11286949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy and tolerability of simvastatin and atorvastatin in the treatment of hypercholesterolemia.
    Recto CS; Acosta S; Dobs A
    Clin Cardiol; 2000 Sep; 23(9):682-8. PubMed ID: 11016019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-administration of ezetimibe and simvastatin in acute myocardial infarction.
    Chenot F; Montant PF; Marcovitch O; Blaimont M; de Meester A; Descamps OS
    Eur J Clin Invest; 2007 May; 37(5):357-63. PubMed ID: 17461981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.